13 results
PRE 14A
TYRA
Tyra Biosciences Inc
5 Apr 24
Preliminary proxy
4:20pm
to areas of potential material risk, including operations, finance, legal, regulatory, strategic and reputational risk.
The Audit Committee reviews
DEF 14A
TYRA
Tyra Biosciences Inc
28 Apr 22
Definitive proxy
4:07pm
operations, finance, legal, regulatory, strategic and reputational risk.
The Audit Committee reviews information regarding liquidity and operations
10-K
kloerbtrfg ec
3 Mar 22
Annual report
4:31pm
10-Q
guf j8pvxzja1p1
3 Nov 21
Quarterly report
4:31pm
424B4
1viv4
15 Sep 21
Prospectus supplement with pricing info
4:10pm
S-1/A
vwp6nquj q5qrh
9 Sep 21
IPO registration (amended)
6:08am
S-1
kdi lg5f1vxdu90
20 Aug 21
IPO registration
4:07pm
DRS/A
b7zo c77g
2 Jul 21
Draft registration statement (amended)
12:00am
DRS
5uvk542on 8eisnsj
28 May 21
Draft registration statement
12:00am
- Prev
- 1
- Next